DENVER, March 29, 2019 /PRNewswire/ -- Medicine Man Technologies, Inc. (MDCL) ("Medicine Man Technologies" or "Company"), a rapidly growing, vertically integrated cannabis operator, today announced that the Company will present at the Spring Investor Summit being held on April 1-2, 2019, at the Essex House in New York City.
Date: Monday, April 1,
2019
Presentation Time: 10:00 AM ET – Track
3
Location: The Essex House, NYC
Joe Puglise, COO of Medicine Man Technologies, will deliver an overview of the Company, highlighting two pending acquisitions of MedPharm Holdings, LLC, and Medicine Man Denver, and provide an overview of its financial and operating performance as well as details on its strategic goals as a vertically integrated cannabis brand and operator.
Mr. Puglise will also serve as a guest speaker for the Cannabis Panel at noon ET, which will focus on key industry trends and address relevant questions regarding the revolutionizing of cannabis in recent years. Mr. Puglise will be available for one-on-one meetings with investors.
The Spring Investor Summit is an exclusive event dedicated to connecting small and micro-cap companies with high-level, institutional, and retail investors. The event's focus is to highlight the most captivating publicly traded companies under $5 billion in market cap across all industries and sectors. The conference will feature 200 presenting companies, 1,200 institutional and retail investors, 2,000 one-on-one meetings, as well as a variety of industry-specific panels.
About Medicine Man
Technologies
Medicine Man Technologies is a fully
integrated operator in the cannabis industry, offering consulting,
retail pharma-grade products, and turnkey solutions for cannabis
cultivators for over a decade. Medicine Man Technologies is
leveraging its expertise and intellectual property to vertically
integrate retail, cultivation, formulation, and distribution
operations. The Company's client portfolio includes active and past
clients in 18 states and seven countries.
Forward-Looking Statements
This press
release contains "forward-looking statements." Such statements may
be preceded by the words "intends," "may," "will," "plans,"
"expects," "anticipates," "projects," "predicts," "estimates,"
"aims," "believes," "hopes," "potential," or similar words.
Forward-looking statements are not guarantees of future
performance, are based on certain assumptions, and are subject to
various known and unknown risks and uncertainties, many of which
are beyond the Company's control, and cannot be predicted or
quantified. Consequently, actual results may differ materially from
those expressed or implied by such forward-looking statements. Such
risks and uncertainties include, without limitation, risks and
uncertainties associated with (i) our inability to manufacture our
products and product candidates on a commercial scale on our own,
or in collaboration with third parties; (ii) difficulties in
obtaining financing on commercially reasonable terms; (iii) changes
in the size and nature of our competition; (iv) loss of one or more
key executives or scientists; and (v) difficulties in securing
regulatory approval to market our products and product candidates.
More detailed information about the Company and the risk factors
that may affect the realization of forward-looking statements is
set forth in the Company's filings with the Securities and Exchange
Commission (SEC), including the Company's Annual Report on Form
10-K and its Quarterly Reports on Form 10-Q. Investors and security
holders are urged to read these documents free of charge on the
SEC's website at http://www.sec.gov. The Company assumes
no obligation to publicly update or revise its forward-looking
statements as a result of new information, future events, or
otherwise.
Investor Relations Contact:
[email protected]
1-866-348-1997
View original content:http://www.prnewswire.com/news-releases/medicine-man-technologies-inc-to-present-and-serve-on-cannabis-panel-at-2019-spring-investor-summit-300820685.html